Key result
SPISE and METS-IR effectively predict pediatric MASLD, with SPISE outperforming standard lipid indices in females.
Why the study?
Are insulin resistance indices (TG/HDL, TyG, SPISE, METS-IR) effective predictors of pediatric MASLD?
Cross-Sectional (n=1,410)
Yes
Are insulin resistance indices (TG/HDL, TyG, SPISE, METS-IR) effective predictors of pediatric MASLD?
Answers are grounded in this paper and cite their sources.
METS-IR and SPISE are effective, non-invasive markers for predicting pediatric MASLD, offering practical screening tools derived from routine laboratory tests.
Background & Aims: We investigated the triglyceride-to-high density lipoprotein (HDL) ratio (TG/HDL), triglyceride-glucose index (TyG), single-point insulin sensitivity estimator (SPISE), and metabolic score for insulin resistance (METS-IR) as potential predictors of pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) by addressing the limited research on insulin-resistance markers in this population. Methods: This cross-sectional study included data from 1,150 and 260 youths from the National Health and Nutrition Examination Survey (NHANES) and a real-world clinic, respectively. Hepatic steatosis was assessed using transient elastography and abdominal sonography. Logistic regression analysis was performed using MASLD as the dependent variable. Receiver operating characteristic (ROC) curves were used to evaluate predictability. In the female group, the AUC for SPISE was significantly higher than that for TG/HDL or TyG. Conclusions: METS-IR and SPISE are effective, non-invasive markers for predicting pediatric MASLD, which offer valuable tools for early detection and improved clinical management. Impact and implications: The increasing prevalence of pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) and its strong association with cardiometabolic risk factors underscore the need for effective early detection tools. Our study demonstrates that single-point insulin sensitivity estimator (SPISE) and metabolic score for insulin resistance (METS-IR) are superior, non-invasive markers for predicting MASLD in children and adolescents, with validated cut-off values applicable to both population-based and real-world clinical settings. These findings are particularly relevant for clinicians and healthcare policymakers, as they provide practical, easily accessible screening tools derived from routine laboratory tests, aiding in the early identification and risk stratification of pediatric MASLD. However, given the study's retrospective design and variations in diagnostic methods across datasets, further validation in larger, diverse cohorts is warranted to refine age-specific cut-off values and optimize screening approaches.
No takes yet. Share an insight, caveat, or question.
Song et al. (2025) conducted a cross-sectional in Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) (n=1,410). Insulin resistance indices (SPISE, METS-IR, TG/HDL, TyG) was evaluated on Predictability of pediatric MASLD (p=<0.001). METS-IR and SPISE are effective non-invasive markers for predicting pediatric MASLD, with SPISE showing a significantly higher AUC than TG/HDL or TyG in females.
Synapse has enriched 10 related papers. Consider them for comparative context: